Isaac Manke is a life sciences venture capitalist. He currently serves as a General Partner at Acorn BioVentures.
At firms with a similar stage, sector and check size.



One email when Isaac's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckIsaac Manke is a life sciences venture capitalist. He currently serves as a General Partner at Acorn BioVentures.
Isaac Manke invests through Acorn Bioventures, which writes checks of $100K to $10M at seed, series a, series b.
A warm intro from a founder Acorn Bioventures backed works best.
research scientist at Massachusetts Institute of Technology; Senior Analyst at Health Advances; Biotechnology Equity Research group at Deutsche Bank; Associate Equity Analyst at Sanford C. Bernstein; General Partner at New Leaf Venture Partners.
Last updated 2026-10-15. Is this you? Ask for a correction.